Dottikon ES Holding AG (LON:0ACK)

Market Cap	3.26B -16.1%
Revenue (ttm)	415.34M +12.0%
Net Income	97.81M -1.9%
EPS	7.08 -1.9%
Shares Out	n/a
PE Ratio	33.35
Forward PE	22.18
Dividend	n/a
Ex-Dividend Date	n/a

Volume	109
Open	259.00
Previous Close	259.00
Day's Range	257.00 - 262.25
52-Week Range	256.00 - 395.00
Beta	0.99
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 27, 2026

About Dottikon ES Holding AG

Dottikon ES Holding AG manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries. The company’s chemicals and intermediates include amines, anilines, azaindoles, benzimidazoles, benzoic acid derivatives, benzyl compounds, boron building blocks, chiral compounds, cyclohexane derivatives, cyclopropyl building blocks, indazoles, indoles, N-heterocycles, nitrate esters, nitroaromatic compounds, O-heterocycles, phenols and anisoles, and pyridine buildin...

• Industry: Industrial Organic Chemicals
• Founded: 1913
• Employees: 900
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0ACK

Financial Performance

In fiscal year 2026, Dottikon ES Holding AG's revenue was 439.92 million, an increase of 12.03% compared to the previous year's 392.68 million. Earnings were 103.60 million, a decrease of -1.87%.

Financial numbers in CHF

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 26, 2026

Data Sources Report a data error